A high level and a pro-tumor role of NEP have been indicated, e.g., in colon and gastric cancers, melanoma, and osteosarcoma; hence, in certain tumor types, NEP inhibitors appear to exert anti-cancer effects [6,9,10,11,12,13]. This evidence concerns the gene MME and melanoma.